Publication | Closed Access

An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin

Pharmaceutical SciencePharmacologyLiposomal DoxorubicinPharmacotherapyCycle DependenceOpen-label StudyMedicinePhysiologically-based Pharmacokinetic ModelingPharmacokineticsDrug Resistance